//= $__courseRemotePath ?>//= $__courseID ?>
//= $__courseRemotePath ?>
This course was last updated on
March 31, 2019
CME credit has expired.
In this activity, Dr. Courtney Thornburg of the Hemophilia and Thrombosis Treatment Center at Rady Children's Hospital in San Diego discusses the clinical relevance of hemophilia abstracts presented at the 2018 American Society of Hematology Annual Meeting. Dr. Thornburg will discuss these abstracts in the context of 4 cases of patients with hemophilia A or hemophilia B, and provides her expert opinion of how research in the treatment of hemophilia can guide treatment.
Enter your information to begin.
//= $__courseRemotePath ?>//= $__rootRemotePath ?>
- Hemophilia A
- Hemophilia B
- Extended half-life factor replacement
- Inhibitor formation during treatment for hemophilia
- Factor VIII replacement
- Factor IX replacement
- Prophylactic treatment
Courtney Thornburg, MD, MS
Director, Hemophilia and Thrombosis Treatment Center
Rady Children's Hospital, San Diego
Professor, Clinical Pediatrics
UC San Diego School of Medicine
1.00 AMA PRA Category 1 Credit™.
||March 31, 2019
||March 30, 2020
Other Healthcare Providers
This activity is supported by an independent educational grant from Bioverativ Inc.